Neerjesh P, Rajkishor Singh, Vipender Singh Chopra, Dharti N, Kavita Dhar, and Sanjay Kumar Singh. “Would Other Oral Hypoglycaemics Persist As an Adequate 1ST Line Add-on Therapy to Metformin in Patients With Type 2 Diabetes Mellitus? No, it’s Time to Refocus!”. World Journal of Pharmaceutical Sciences, vol. 3, no. 12, Dec. 2015, pp. 2444-51, https://wjpsonline.com/index.php/wjps/article/view/oral-hypoglycaemics-metformin-diabetes-mellitus.